The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cascino, I.
Right arrow Articles by Ruberti, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cascino, I.
Right arrow Articles by Ruberti, G.

The Journal of Immunology, Vol 154, Issue 6 2706-2713, Copyright © 1995 by American Association of Immunologists

ARTICLES

Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing

I Cascino, G Fiucci, G Papoff and G Ruberti
Department of Immunobiology, Institute of Cell Biology, National Research Council, Rome, Italy.

Fas/Apo-1 molecule is an apoptosis-signaling cell surface Ag belonging to the TNFR family. To investigate the possibility that soluble forms of the Fas receptor are expressed in human cells, we analyzed Fas mRNA transcripts obtained from activated peripheral mononuclear cells of healthy donors and from human tumor cell lines. We identified and characterized three human mRNA Fas variants: FasTMDel, FasDel2, and FasDel3. To determine whether the three transcripts were derived by alternative splicing, the Fas genomic intron/exon organization of the regions surrounding the deleted sequences was analyzed in Fas clones isolated from a human genomic library. Expression of the transcripts was studied in COS cells transiently transfected with the FasTMDel, FasDel2, and FasDel3 cDNAs. Immunocytochemical and in vitro apoptosis inhibition studies suggest that the transcripts are expressed as soluble Fas proteins that may play a functional role in the regulation of apoptosis.


This article has been cited by other articles:


Home page
 StrokeHome page
P. Delgado, E. Cuadrado, A. Rosell, J. Alvarez-Sabin, A. Ortega-Aznar, M. Hernandez-Guillamon, A. Penalba, C. A. Molina, and J. Montaner
Fas System Activation in Perihematomal Areas After Spontaneous Intracerebral Hemorrhage
Stroke, June 1, 2008; 39(6): 1730 - 1734.
[Abstract] [Full Text] [PDF]

Home page
 RNAHome page
Z. Wang and C. B. Burge
Splicing regulation: From a parts list of regulatory elements to an integrated splicing code
RNA, May 1, 2008; 14(5): 802 - 813.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
Y. H. Jun, C. H. Nahm, and J. W. Choi
Associations between Body Hydration Status and Serum Markers of Apoptosis in Elderly Persons
Ann. Clin. Lab. Sci., January 1, 2008; 38(1): 88 - 91.
[Full Text] [PDF]

Home page
 BloodHome page
J. Roesler, J.-M. Izquierdo, M. Ryser, A. Rosen-Wolff, M. Gahr, J. Valcarcel, M. J. Lenardo, and L. Zheng
Haploinsufficiency, rather than the effect of an excessive production of soluble CD95 (CD95{Delta}TM), is the basis for ALPS Ia in a family with duplicated 3' splice site AG in CD95 intron 5 on one allele
Blood, September 1, 2005; 106(5): 1652 - 1659.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Nadal, J. Maurel, R. Gallego, A. Castells, R. Longaron, M. Marmol, S. Sanz, R. Molina, M. Martin-Richard, and P. Gascon
FAS/FAS Ligand Ratio: A Marker of Oxaliplatin-Based Intrinsic and Acquired Resistance in Advanced Colorectal Cancer
Clin. Cancer Res., July 1, 2005; 11(13): 4770 - 4774.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Drynda, P. H. A. Quax, M. Neumann, W. H. van der Laan, G. Pap, S. Drynda, I. Meinecke, J. Kekow, W. Neumann, T. W. J. Huizinga, et al.
Gene Transfer of Tissue Inhibitor of Metalloproteinases-3 Reverses the Inhibitory Effects of TNF-{alpha} on Fas-Induced Apoptosis in Rheumatoid Arthritis Synovial Fibroblasts
J. Immunol., May 15, 2005; 174(10): 6524 - 6531.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. Eidsmo, S. Nylen, A. Khamesipour, M.-A. Hedblad, F. Chiodi, and H. Akuffo
The Contribution of the Fas/FasL Apoptotic Pathway in Ulcer Formation during Leishmania major-Induced Cutaneous Leishmaniasis
Am. J. Pathol., April 1, 2005; 166(4): 1099 - 1108.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Monari, E. Pericolini, G. Bistoni, A. Casadevall, T. R. Kozel, and A. Vecchiarelli
Cryptococcus neoformans Capsular Glucuronoxylomannan Induces Expression of Fas Ligand in Macrophages
J. Immunol., March 15, 2005; 174(6): 3461 - 3468.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
J. W. Choi and S. K. Kim
Relationships of Soluble APO-1 (Fas/CD95) Concentrations, Obesity, and Serum Lipid Parameters in Healthy Adults
Ann. Clin. Lab. Sci., January 1, 2005; 35(3): 290 - 296.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Pinti, L. Troiano, M. Nasi, C. Bellodi, R. Ferraresi, C. Mussi, G. Salvioli, and A. Cossarizza
Balanced Regulation of mRNA Production for Fas and Fas Ligand in Lymphocytes From Centenarians: How the Immune System Starts Its Second Century
Circulation, November 9, 2004; 110(19): 3108 - 3114.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. Clementi, L. Dagna, U. Dianzani, L. Dupre, I. Dianzani, M. Ponzoni, A. Cometa, A. Chiocchetti, M. G. Sabbadini, C. Rugarli, et al.
Inherited Perforin and Fas Mutations in a Patient with Autoimmune Lymphoproliferative Syndrome and Lymphoma
N. Engl. J. Med., September 30, 2004; 351(14): 1419 - 1424.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Hallermalm, A. De Geer, R. Kiessling, V. Levitsky, and J. Levitskaya
Autocrine Secretion of Fas Ligand Shields Tumor Cells from Fas-Mediated Killing by Cytotoxic Lymphocytes
Cancer Res., September 15, 2004; 64(18): 6775 - 6782.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
J.T. Bridgham and A.L. Johnson
Alternatively Spliced Variants of Gallus gallus TNFRSF23 Are Expressed in the Ovary and Differentially Regulated by Cell Signaling Pathways
Biol Reprod, April 1, 2004; 70(4): 972 - 979.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
S. L. Straszewski-Chavez, V. M. Abrahams, E. F. Funai, and G. Mor
X-linked inhibitor of apoptosis (XIAP) confers human trophoblast cell resistance to Fas-mediated apoptosis
Mol. Hum. Reprod., January 1, 2004; 10(1): 33 - 41.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
B. Lainez, J. M. Fernandez-Real, X. Romero, E. Esplugues, J. D. Canete, W. Ricart, and P. Engel
Identification and characterization of a novel spliced variant that encodes human soluble tumor necrosis factor receptor 2
Int. Immunol., January 1, 2004; 16(1): 169 - 177.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
O. V. Proussakova, N. A. Rabaya, A. B. Moshnikova, E. S. Telegina, A. Turanov, M. G. Nanazashvili, and I. P. Beletsky
Oligomerization of Soluble Fas Antigen Induces Its Cytotoxicity
J. Biol. Chem., September 19, 2003; 278(38): 36236 - 36241.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
L. Jiang, Y. Huang, S. Hunyor, and C.G. dos Remedios
Cardiomyocyte apoptosis is associated with increased wall stress in chronic failing left ventricle
Eur. Heart J., April 2, 2003; 24(8): 742 - 751.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. Shen, A. C. T. Liang, L. Lu, W. Y. Au, Y.-L. Kwong, R. H. S. Liang, and G. Srivastava
Frequent Deletion of Fas Gene Sequences Encoding Death and Transmembrane Domains in Nasal Natural Killer/T-Cell Lymphoma
Am. J. Pathol., December 1, 2002; 161(6): 2123 - 2131.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
J. J. Ryon, W. J. Moss, M. Monze, and D. E. Griffin
Functional and Phenotypic Changes in Circulating Lymphocytes from Hospitalized Zambian Children with Measles
Clin. Vaccine Immunol., September 1, 2002; 9(5): 994 - 1003.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. L. McNees, C. T. Garnett, and L. R. Gooding
The Adenovirus E3 RID Complex Protects Some Cultured Human T and B Lymphocytes from Fas-Induced Apoptosis
J. Virol., August 28, 2002; 76(19): 9716 - 9723.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. H. Liu, S. Wei, T. Lamy, Y. Li, P.K. Epling-Burnette, J. Y. Djeu, and T. P. Loughran Jr
Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia
Blood, July 30, 2002; 100(4): 1449 - 1453.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Lipton, S. M. Ali, K. Leitzel, V. Chinchilli, L. Witters, L. Engle, D. Holloway, P. Bekker, and C. R. Dunstan
Serum Osteoprotegerin Levels in Healthy Controls and Cancer Patients
Clin. Cancer Res., July 1, 2002; 8(7): 2306 - 2310.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
U. Joashi, S. M. Tibby, C. Turner, A. Mayer, C. Austin, D. Anderson, A. Durward, and I. A. Murdoch
Soluble Fas may be a proinflammatory marker after cardiopulmonary bypass in children
J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 137 - 144.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Del Poeta, L. Maurillo, A. Venditti, F. Buccisano, A. M. Epiceno, G. Capelli, A. Tamburini, G. Suppo, A. Battaglia, M. I. Del Principe, et al.
Clinical significance of CD38 expression in chronic lymphocytic leukemia
Blood, November 1, 2001; 98(9): 2633 - 2639.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Feldkamp, E. Pascher, M. Schott, P. Goretzki, J. Seissler, and W. A. Scherbaum
Soluble Fas Is Increased in Hyperthyroidism Independent of the Underlying Thyroid Disease
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4250 - 4253.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
J.T. Bridgham and A.L. Johnson
Expression and Regulation of Fas Antigen and Tumor Necrosis Factor Receptor Type I in Hen Granulosa Cells
Biol Reprod, September 1, 2001; 65(3): 733 - 739.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Ugurel, G. Rappl, W. Tilgen, and U. Reinhold
Increased Soluble CD95 (sFas/CD95) Serum Level Correlates with Poor Prognosis in Melanoma Patients
Clin. Cancer Res., May 1, 2001; 7(5): 1282 - 1286.
[Abstract] [Full Text]

Home page
 Ann Rheum DisHome page
M W van der Linden, T van Lopik, L A Aarden, R G J Westendorp, and T W J Huizinga
Soluble CD95 concentrations are increased in patients with severe systemic lupus erythematosus, but not in their first degree relatives
Ann Rheum Dis, March 1, 2001; 60(3): 237 - 241.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
M. José de los Santos, D. J. Anderson, C. Racowsky, and J. A. Hill
Presence of Fas-Fas Ligand System and Bcl-2 Gene Products in Cells and Fluids from Gonadotropin-Stimulated Human Ovaries1
Biol Reprod, December 1, 2000; 63(6): 1811 - 1816.
[Abstract] [Full Text]

Home page
 Br. J. Ophthalmol.Home page
S. Sugita, C. Taguchi, H. Takase, K. Sagawa, J. Sueda, K. Fukushi, N. Hikita, T. Watanabe, K. Itoh, and M. Mochizuki
Soluble Fas ligand and soluble Fas in ocular fluid of patients with uveitis
Br. J. Ophthalmol., October 1, 2000; 84(10): 1130 - 1134.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
R. Konno, T. Takano, S. Sato, and A. Yajima
Serum Soluble Fas Level as a Prognostic Factor in Patients with Gynecological Malignancies
Clin. Cancer Res., September 1, 2000; 6(9): 3576 - 3580.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
G. Bellone, C. Smirne, A. Carbone, K. Mareschi, L. Dughera, E. C. Farina, O. Alabiso, G. Valente, G. Emanuelli, and U. Rodeck
Production and Pro-Apoptotic Activity of Soluble CD95 Ligand in Pancreatic Carcinoma
Clin. Cancer Res., June 1, 2000; 6(6): 2448 - 2455.
[Abstract] [Full Text]

Home page
 Obstet GynecolHome page
C.-D. HSU, S.-F. HONG, H. HARIRAH, R. BAHADO-SINGH, and L.-C. LU
Amniotic Fluid Soluble Fas Levels in Intra-Amniotic Infection
Obstet. Gynecol., May 1, 2000; 95(5): 667 - 670.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Jenkins, M. Keir, and J. M. McCune
A Membrane-bound Fas Decoy Receptor Expressed by Human Thymocytes
J. Biol. Chem., March 10, 2000; 275(11): 7988 - 7993.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Papoff, P. Hausler, A. Eramo, M. G. Pagano, G. Di Leve, A. Signore, and G. Ruberti
Identification and Characterization of a Ligand-independent Oligomerization Domain in the Extracellular Region of the CD95 Death Receptor
J. Biol. Chem., December 31, 1999; 274(53): 38241 - 38250.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Ayroldi, F. D'Adamio, O. Zollo, M. Agostini, R. Moraca, L. Cannarile, G. Migliorati, D. V. Delfino, and C. Riccardi
Cloning and Expression of a Short Fas Ligand: A New Alternatively Spliced Product of the Mouse Fas Ligand Gene
Blood, November 15, 1999; 94(10): 3456 - 3467.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Ueno, M. Toi, and T. Tominaga
Circulating Soluble Fas Concentration in Breast Cancer Patients
Clin. Cancer Res., November 1, 1999; 5(11): 3529 - 3533.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
G. A. WANNER, L. MICA, E. WANNER-SCHMID, S. A. KOLB, H. HENTZE, O. TRENTZ, and W. ERTEL
Inhibition of caspase activity prevents CD95-mediated hepatic microvascular perfusion failure and restores Kupffer cell clearance capacity
FASEB J, July 1, 1999; 13(10): 1239 - 1248.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
S. G. Payne, S. C. Smith, S. T. Davidge, P. N. Baker, and L. J. Guilbert
Death Receptor Fas/Apo-1/CD95 Expressed by Human Placental Cytotrophoblasts Does Not Mediate Apoptosis
Biol Reprod, May 1, 1999; 60(5): 1144 - 1150.
[Abstract] [Full Text]

Home page
 J. Exp. Med.Home page
T. Maeda, Y. Yamada, R. Moriuchi, K. Sugahara, K. Tsuruda, T. Joh, S. Atogami, K. Tsukasaki, M. Tomonaga, and S. Kamihira
Fas Gene Mutation in the Progression of Adult T Cell Leukemia
J. Exp. Med., April 5, 1999; 189(7): 1063 - 1071.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. S. Griffith, C. T. Rauch, P. J. Smolak, J. Y. Waugh, N. Boiani, D. H. Lynch, C. A. Smith, R. G. Goodwin, and M. Z. Kubin
Functional Analysis of TRAIL Receptors Using Monoclonal Antibodies
J. Immunol., March 1, 1999; 162(5): 2597 - 2605.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Saas, J. Boucraut, A.-L. Quiquerez, V. Schnuriger, G. Perrin, S. Desplat-Jego, D. Bernard, P. R. Walker, and P.-Y. Dietrich
CD95 (Fas/Apo-1) as a Receptor Governing Astrocyte Apoptotic or Inflammatory Responses: A Key Role in Brain Inflammation?
J. Immunol., February 15, 1999; 162(4): 2326 - 2333.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. J. Yun, P. M. Chaudhary, G. L. Shu, J. K. Frazer, M. K. Ewings, S. M. Schwartz, V. Pascual, L. E. Hood, and E. A. Clark3
OPG/FDCR-1, a TNF Receptor Family Member, Is Expressed in Lymphoid Cells and Is Up-Regulated by Ligating CD40
J. Immunol., December 1, 1998; 161(11): 6113 - 6121.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. K. A. Prasad, G. Papoff, A. Zeuner, E. Bonnin, M. D. Kazatchkine, G. Ruberti, and S. V. Kaveri
Therapeutic Preparations of Normal Polyspecific IgG (IVIg) Induce Apoptosis in Human Lymphocytes and Monocytes: A Novel Mechanism of Action of IVIg Involving the Fas Apoptotic Pathway
J. Immunol., October 1, 1998; 161(7): 3781 - 3790.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Albanese, S. Meterissian, M. Kontogiannea, C. Dubreuil, A. Hand, S. Sorba, and N. Dainiak
Biologically Active Fas Antigen and Its Cognate Ligand Are Expressed on Plasma Membrane-Derived Extracellular Vesicles
Blood, May 15, 1998; 91(10): 3862 - 3874.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Tamiya, K.-i. Etoh, H. Suzushima, K. Takatsuki, and M. Matsuoka
Mutation of CD95 (Fas/Apo-1) Gene in Adult T-Cell Leukemia Cells
Blood, May 15, 1998; 91(10): 3935 - 3942.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. M. Liem, T. van Lopik, A. E.M. van Nieuwenhuijze, H. C. van Houwelingen, L. Aarden, and E. Goulmy
Soluble Fas Levels in Sera of Bone Marrow Transplantation Recipients Are Increased During Acute Graft-Versus-Host Disease But Not During Infections
Blood, February 15, 1998; 91(4): 1464 - 1468.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
Y. Taniguchi, T. Furukawa, T. Tun, H. Han, and T. Honjo
LIM Protein KyoT2 Negatively Regulates Transcription by Association with the RBP-J DNA-Binding Protein
Mol. Cell. Biol., January 1, 1998; 18(1): 644 - 654.
[Abstract] [Full Text]

Home page
 BloodHome page
T. H. Landowski, N. Qu, I. Buyuksal, J. S. Painter, and W. S. Dalton
Mutations in the Fas Antigen in Patients With Multiple Myeloma
Blood, December 1, 1997; 90(11): 4266 - 4270.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. R. Orlinick, A. Vaishnaw, K. B. Elkon, and M. V. Chao
Requirement of Cysteine-rich Repeats of the Fas Receptor for Binding by the Fas Ligand
J. Biol. Chem., November 14, 1997; 272(46): 28889 - 28894.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. A. Baiocchi, V. P. Khatri, M. J. Lindemann, M. E. Ross, G. Papoff, A. J. Caprio, T. V. Caprio, R. Fenstermaker, G. Ruberti, Z. P. Bernstein, et al.
Phenotypic and Functional Analysis of Fas (CD95) Expression in Primary Central Nervous System Lymphoma of Patients With Acquired Immunodeficiency Syndrome
Blood, September 1, 1997; 90(5): 1737 - 1746.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.